FDA issued a Warning Letter to Celltrion Inc. on 1/26/2018 as a result of this inspection.
483 Celltrion Jun 2017

483 Celltrion Jun 2017

Justin Boyd FDA$119.00 - Available Now

FDA investigators audited the Celltrion - Yeonsu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 02 Jun 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Jun 2017
  • Location: Yeonsu, Korea (the Republic of)
  • FEI: 3005241015
Add To Cart